These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1706047)

  • 1. Colony-stimulating factors for neutropenia in glycogen storage disease Ib.
    Schroten H; Wendel U; Burdach S; Roesler J; Breidenbach T; Schweitzer S; Zeidler C; Welte K
    Lancet; 1991 Mar; 337(8743):736-7. PubMed ID: 1706047
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
    Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
    J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotopic liver transplantation for glycogen storage disease type Ib--treatment with recombinant human granulocyte colony-stimulating factor.
    Lachaux A; Boillot O; Stamm D; Canterino I; Regnier F; Regragui K; Floret D; Hermier M
    Transplant Proc; 1994 Feb; 26(1):265. PubMed ID: 7509094
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycogen storage disease type Ib: infectious complications and measures for prevention.
    Wendel U; Schroten H; Burdach S; Wahn V
    Eur J Pediatr; 1993; 152 Suppl 1():S49-51. PubMed ID: 7686491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
    Wang WC; Crist WM; Ihle JN; Arnold BA; Keating JP
    Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
    Mori PG; Pasino M; Dufour C; Boeri E; Molinari AC
    Blood; 1994 Nov; 84(9):3244-5. PubMed ID: 7524771
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of granulocyte-colony stimulating factor in glycogen storage disease type Ib.
    Zuccotti GV; Longhi R; Flumine P; Stangalini A; Riva E
    J Int Med Res; 1993; 21(5):276-9. PubMed ID: 7509298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic growth factors in children with neutropenia.
    Lehrnbecher T; Welte K
    Br J Haematol; 2002 Jan; 116(1):28-56. PubMed ID: 11841397
    [No Abstract]   [Full Text] [Related]  

  • 9. [Place of CSF in pediatric oncology].
    Hartmann O; Valteau-Couanet D
    Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplantation for type Ib glycogenosis with reversal of cyclic neutropenia.
    Martinez-Olmos MA ; López-Sanromán A; Martín-Vaquero P; Molina-Pérez E; Bárcena R; Vicente E; Candela A ; Pallardo-Sánchez LF
    Clin Nutr; 2001 Aug; 20(4):375-7. PubMed ID: 11478837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors.
    Roe TF; Coates TD; Thomas DW; Miller JH; Gilsanz V
    N Engl J Med; 1992 Jun; 326(25):1666-9. PubMed ID: 1375344
    [No Abstract]   [Full Text] [Related]  

  • 13. Colony-stimulating factors after the treatment of pediatric malignant diseases.
    Schuler D
    Pediatr Hematol Oncol; 1997; 14(1):iii-v. PubMed ID: 9021806
    [No Abstract]   [Full Text] [Related]  

  • 14. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth factors and empiric therapy with antibiotics: should they be used concurrently?
    Schimpff SC
    Ann Intern Med; 1994 Oct; 121(7):538-40. PubMed ID: 7520677
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of infections in patients with neutropenia (a review of the literature with the inclusion of the authors' own data)].
    Ptushkin VV; Bagirova NS; Volkova MA
    Ter Arkh; 1998; 70(7):83-7. PubMed ID: 9742648
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
    Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
    Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.